The DEA's rule change allows other health-care professionals aside from just doctors to prescribe buprenorphine, an effective—but potentially addictive—treatment.
New data on drug and device company payments to doctors largely excludes nurse practitioners and physician assistants, though they play an ever-larger role in health care. One advanced-practice nurse pleaded guilty last month to taking drug company kickbacks.